AKT1 and lung cancer: Mechanistically, ABN-B leads to the activation of the PI3K/AKT and ERK1/2 MAPK pathways via the production of mitochondrial ROS, which resulted in the induction of apoptosis and cell cycle arrest at G2/M in human lung cancer cells (Figure 8E).